Beta 2 adrenergic receptor polymorphisms in cystic fibrosis

Pediatric Pulmonology

Volumn 39, Issue 6, 2005, Pages 544-550

  Hart, Meeghan A ^a,c   Konstan, Michael W ^a   Darrah, Rebecca J ^a   Schluchter, Mark D ^a   Storfer Isser, Amy ^a   Xue, Lintong ^a   Londono, Douglas ^b   Goddard, Katrina A B ^b   Drumm, Mitchell L ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Bronchodilators; CFTR; Cystic fibrosis; Pulmonary function tests; Single nucleotide polymorphisms

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; SALBUTAMOL;

ADOLESCENT; ADRB2 GENE; ADRENERGIC SYSTEM; ADULT; ARTICLE; BRONCHODILATATION; CHILD; CODON; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN GENOME; LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SPIROMETRY;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; RESPIRATORY FUNCTION TESTS;

EID: 18844458294     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.20210     Document Type: Article

References (22)

1. Sachidanandam R, Weissman D, Schmidt S, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001;409:928-933.
2. Larj M, Bleecker E. Effects of β2-agonists on airway tone and bronchial responsiveness. J Allergy Clin Immunol 2002;110:304-312.
3. Reihsaus E, Innis M, MacIntyre N, Liggett S. Mutations in the gene coding for the beta-2 adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993;8:334-349.
4. Israel E, Drazen J, Liggett S, et al. The effect of polymorphisms of the β2-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000;162:75-80.
5. Martinez F, Graves P, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the β2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997;100:3184-3188.
6. Hamosh A, Corey M, Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 1993;329:1308-1313.
7. Konstan M, Butler S, Schindlow D, Morgan W, Julius J, Johnson C, for Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Patterns of medical practice in cystic fibrosis: part II - use of therapies. Pediatr Pulmonol 1999;28:248-254.
8. Bennett W. Effect of β-adrenergic agonists on mucociliary clearance. J Allergy Clin Immunol 2002;110:291-297.
9. Konstan M, Butler S, Wohl M, Stoddarf M, Matousek R, Wagener J, Johnson C, Morgan W. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 2003;142:624-630.
10. Buscher R, Eilmes KJ, Grasemann H, Torres B, Knauer N, Sroka K, Insel PA, Ratjen F. β2adrenoceptor gene polymorphisms in cystic fibrosis lung disease. Pharmacogenetics 2002;12:347-353.
11. American Association for Respiratory Care. Clinical practice guidelines: spirometry, 1996 update. Respir Care 1996;41:629-636.
12. American Thoracic Society. Standardization of spirometry - 1987 update. Am J Respir Crit Care Med 1995;152:1107-1136.
13. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-734.
14. Truett GE. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and TRIS (HotSHOT). Biotechniques 2000;29:52-54.
15. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-989.
16. Stephens M, Smith NJ, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population data. Am J Hum Genet 2003;73:1162-1169.
17. Drysdale C, McGraw D, Stack C, Stephens C, Judson R, Nandabalan K, Arnold K, Ruano G, Liggett S. Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000;97:10483-10488.
18. Green S, Turki J, Innis M, Liggett S. Amino-terminal polymorhisms of the human β2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994;33:9414-9419.
19. Liggett SB. Pharmacogenetics of β1 and β2 adrenergic receptors. Pharmacology 2000;61:167-173.
20. Liggett SB. The pharmacogenetics of β2 adrenergic receptors: relevance to asthma. J Allergy Clin Immunol 2000;105:487-492.
21. Holzer FJ, Olinsky A, Phelan PD. Variability of airways hyperreactivity and allergy in cystic fibrosis. Arch Dis Child 1981;56:455-459.
22. Hordvik NL, Konig P, Morris D, Kreutz C, Barbero GJ. A longitudinal study of bronchodilator responsiveness in cystic fibrosis. Am Rev Respir Dis 1985;131:889-893.